Sara Colombo Mottaz
Biographic Data
| ID | 10035628 |
|---|---|
| NAME | Sara Colombo Mottaz |
| GIVEN NAMES | Sara Colombo |
| FAMILY NAME | Mottaz |
| SIGNATURE | MOTTAZ S C |
| AFFILIATIONS | Nestlé (Switzerland) |
| ORCID | 0000-0002-4594-9717 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2022 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Decentralized clinical trials are better for the participants and for the planet
Introduction: Novel technologies have enabled the decentralization of many aspects of clinical trials, but little research has been done on the impact of these changes on the participant experience, trial operations, or the environment. Methods: A fully decentralized clinical trial conducted in Singapore is used as a case study to evaluate the operational outcomes, environmental impact (via life cycle assessment), and participants experience (qua…
Sars-CoV-2 infection among employees working from home and on site
During the COVID-19 pandemic, many companies implemented working from home to mitigate the spread of the disease among their employees. Using data from Corona Immunitas Nestlé , a seroepidemiological study conducted among employees from two Nestlé sites in Switzerland, we aimed to investigate whether there was a difference in SARS-CoV-2 infection rates between employees working most of the time from home and employees mobilized in a workplace equ…
No prominent works on this page.
Sars-CoV-2 infection among employees working from home and on site
During the COVID-19 pandemic, many companies implemented working from home to mitigate the spread of the disease among their employees. Using data from Corona Immunitas Nestlé , a seroepidemiological study conducted among employees from two Nestlé sites in Switzerland, we aimed to investigate whether there was a difference in SARS-CoV-2 infection rates between employees working most of the time from home and employees mobilized in a workplace equ…
Decentralized clinical trials are better for the participants and for the planet
Introduction: Novel technologies have enabled the decentralization of many aspects of clinical trials, but little research has been done on the impact of these changes on the participant experience, trial operations, or the environment. Methods: A fully decentralized clinical trial conducted in Singapore is used as a case study to evaluate the operational outcomes, environmental impact (via life cycle assessment), and participants experience (qua…
Medicine (2 works) · Biosimilars and Bioanalytical Methods (1 work) · Business (1 work) · Clinical trial (1 work) · COVID-19 and Mental Health (1 work) · Decentralization (1 work) · Demography (1 work) · Disease (1 work) · Engineering (1 work) · Environmental health (1 work)